SCHEMBL8311019

SCHEMBL8311019

CCCCCC(=O)N1CCN(C(=O)c2ccc(Nc3nccc(-c4ccc(Cl)cc4)n3)cc2)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIK3CA P42336 2/20 0.48
▸ PIK3CB P42338 2/20 0.48
▸ PIK3CG P48736 2/20 0.48
▸ JAK2 O60674 9/20 0.47
▸ JAK3 P52333 5/20 0.47
▸ CDK1 P06493 1/20 0.47
▸ CDK2 P24941 1/20 0.47
▸ IKBKB O14920 4/20 0.47
▸ CHUK O15111 3/20 0.47
▸ MAPKAPK2 P49137 1/20 0.46
▸ HDAC1 Q13547 5/20 0.46
▸ HDAC6 Q9UBN7 5/20 0.46
▸ ACVR1 Q04771 1/20 0.45
▸ IKBKG Q9Y6K9 1/20 0.45
▸ JAK1 P23458 2/20 0.44
▸ TYK2 P29597 2/20 0.44
▸ CAMK2D Q13557 1/20 0.44
▸ HDAC3 O15379 1/20 0.44
▸ NCOR1 O75376 1/20 0.44
▸ HDAC2 Q92769 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14021080 0.90 PIK3CA (0.52) PIK3CAPIK3CBPIK3CGJAK2JAK3
SCHEMBL14063843 0.90 IKBKB (0.47) PIK3CAPIK3CBPIK3CGJAK2JAK3
SCHEMBL14063849 0.88 PIK3CA (0.48) PIK3CAPIK3CBPIK3CGJAK2JAK3
SCHEMBL14021629 0.87 JAK2 (0.54) PIK3CAPIK3CBPIK3CGJAK2JAK3
SCHEMBL14063846 0.86 PIK3CA (0.50) PIK3CAPIK3CBPIK3CGJAK2JAK3
SCHEMBL8311018 0.86 JAK2 (0.61) PIK3CAPIK3CBPIK3CGJAK2JAK3
SCHEMBL14063844 0.85 PIK3CA (0.54) PIK3CAPIK3CBPIK3CGJAK2JAK3
SCHEMBL14063837 0.85 CDK2 (0.52) PIK3CAPIK3CBPIK3CGJAK2JAK3
SCHEMBL14063842 0.85 JAK2 (0.52) PIK3CAPIK3CBPIK3CGJAK2JAK3
SCHEMBL8312167 0.85 JAK2 (0.49) PIK3CAPIK3CBPIK3CGJAK2JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7442699-B2 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto SIGNAL PHARMACEUTICALS, LLC (US) 2008-10-28 — — US disclosed
US-7442699-B2 Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto SIGNAL PHARMACEUTICALS, LLC (US) 2008-10-28 — — US disclosed
US-7429599-B2 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK SIGNAL PHARMACEUTICALS, LLC (US) 2008-09-30 — — US disclosed
US-7429599-B2 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK SIGNAL PHARMACEUTICALS, LLC (US) 2008-09-30 — — US disclosed
WO-2004084901-A1 METHODS FOR TREATING OR PREVENTING AN INFLAMMATORY OR METABOLIC CONDITION BY INHIBITING JNK SIGNAL PHARMACEUTICALS, LLC (US) 2004-10-07 — — WO disclosed
Send feedback